Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma
Clinical trial NCT01259375 · COMPLETED
Trial details
- NCT number
- NCT01259375
- Sponsor
- University of Utah
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2016-02-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.